Jean-Luc Dompé will be out for HSV for the time being. As a replacement, an actor who played hardly any role in the last ...

In his absence, winter signing Alexander Røssing-Lelesiit got a chance on the left wing. The 18-year-old once again showed ...

MILAN--(BUSINESS WIRE)--Dompé, one of Italy’s leading biopharmaceutical companies, announced today that it has entered into a definitive agreement to acquire 100% of Anabasis Srl, a privately ...

Dompé is a privately owned biopharmaceutical company with 130 years of history and expertise in life sciences. Headquartered in Milan, the company also has operations in Boston, San Francisco ...

Dompé, a leading biopharmaceutical company with operations in Italy and the US, appointed Shannon K. Sullivan as Chief Commercial Officer (CCO).

MILAN, Nov. 26, 2020 /PRNewswire/ -- Dompé farmaceutici Spa and FarmaMondo entered into an exclusive Managed Access Program distribution agreement appointing the FarmaMondo Group as the exclusive ...

MILAN, June 13, 2022 /PRNewswire/ -- Dompé farmaceutici S.p.A ("Dompé") today announced results from its Phase 2 clinical trial demonstrating that, in patients in severe COVID-19 Pneumonia ...

Dompé pha.r.ma s.p.a. and Axxam s.r.l. announced a research collaboration for the discovery and development of novel drugs based on GPCR targets. "The partnership between Dompé pha.r.ma and Axxam ...

Marketing In 3 firsts, Dompé's regenerative eye drop Oxervate wins FDA nod for rare disease By Angus Liu Aug 23, 2018 11:30am drug approval drug launch orphan drug rare diseases ...

Dompé is a private, rapidly scaling international biopharmaceutical company founded in Milan, Italy, with a 130-year legacy of medical innovation. The R&D department of the company is anchored by ...